arginyl-glycyl-aspartic acid has been researched along with methotrexate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jasti, B; Kotamraj, P; Li, X; Russu, WA; Wu, J | 1 |
| Gan, Z; Liu, HM; Wu, H; Wu, HH; Yan, F; Zhou, MJ | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and methotrexate
| Article | Year |
|---|---|
Novel integrin-targeted binding-triggered drug delivery system for methotrexate.
Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Drug Delivery Systems; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaVbeta3; Methotrexate; Models, Molecular; Neoplasms; Oligopeptides; Prodrugs; Protein Binding; Protein Conformation | 2011 |
[Efficacy of internalized RGD-modified echogenic liposomes in diagnosis and treatment in a mouse model of rheumatoid arthritis].
Topics: Animals; Arthritis, Rheumatoid; Human Umbilical Vein Endothelial Cells; Humans; Indocyanine Green; Liposomes; Methotrexate; Mice; Oligopeptides; Particle Size; Ultrasonography | 2017 |